Leaderboard

En | De
Sie sind hier: Gastroenterologie » Oesophagus » Neoplasie 03. Mai 2025
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gallenwege
Leber
Magen-Darm
Oesophagus
Motilitätsstörungen
Neoplasie
Anderes
Pankreas
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 1805  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 36100  
   
The effects of a 3-month walking and dietary education program on the quality of life of patients with esophageal cancer: a 1-year follow-up randomized controlled trial.
Support Care Cancer
Chen HM, Huang CS, Wu YC, Chien LI, Hsu PK.
PMID: 40312569 [PubMed - indexed for MEDLINE]


Clinical characteristics, prognosis, and nomogram for upper esophageal cancer: a SEER database analysis.
Sci Rep
Yang D, Liu Z, Xie J.
PMID: 40307256 [PubMed - indexed for MEDLINE]


Prognostic value of lymph node dissection count in esophageal squamous cell carcinoma: A systematic review and meta-analysis.
Curr Probl Surg
A-Lai GH, Lian L, Zhao YS, Zhong C, Zhong X, Lin YD.
PMID: 40306866 [PubMed - in process]


Endoscopic treatment versus surgical treatment for T1b esophageal cancer: a systematic review and meta-analysis.
Eur J Surg Oncol
Zheng HT, Wang CY, Luo J, Wu YH, Ge QY, Cong ZZ, Shen Y.
PMID: 40306193 [PubMed - as supplied by publisher]


Somatic mosaicism in the buccal mucosa reflects lifestyle and germline risk factors for esophageal squamous cell carcinoma.
Sci Transl Med
Yokoyama A, Watanabe K, Inoue Y, Hirano T, Tamaoki M, Hirohashi K, Kawaguchi S, Ishida Y, Takeuchi Y, Kishimoto Y, Kim SK, Katada C, Nannya Y, Seno H, Ogawa S, Muto M, Kakiuchi N.
PMID: 40305574 [PubMed - indexed for MEDLINE]


Identification of disulfidptosis in esophageal squamous cell carcinoma based on single-cell and bulk RNA-seq data to predict prognosis and treatment response.
Front Immunol
Zhang X, Du J, Lin X, Zhang S, Zeng T, Chen M, Huang G, Chen C, Zheng B.
PMID: 40303412 [PubMed - indexed for MEDLINE]


Neoadjuvant immunochemotherapy for locally advanced esophageal squamous cell carcinoma in real-world practice: an analysis of the clinical outcomes and long-term survival, and the feasibility of using major pathological response as a surrogate endpoint.
Eur J Med Res
Liu J, Wu Z, Zhou S, Lv W, Wang Y, Xia P, Zhu L, Hu J.
PMID: 40301916 [PubMed - indexed for MEDLINE]


Development and validation a radiomics combined clinical model predicts treatment response for esophageal squamous cell carcinoma patients.
BMC Gastroenterol
Yin X, Cui Y, Liu T, Li Z, Liu H, Ma X, Sha X, Ma C, Han D, Yin Y.
PMID: 40301780 [PubMed - indexed for MEDLINE]


Evaluating CSPG4 expression in esophageal basaloid squamous cell carcinoma and conventional squamous cell carcinoma: a multi-institutional retrospective study in China.
Virchows Arch
Jiang D, Xu C, Li Y, Nie L, Tao X, Hu X, Yang M, Li X, Chang X, Wang X, Yang X, Zheng Q, Teng H, He Y, Yuan W, Xiao Y, Deng M, Liu Y, Yu Z, Song Q, Yao J, Zhang X, Xu L, Su J, He M, Han Y, Li Y, Wang C, Liu Y, Nie X, Fan X, Xue L, Mei J, Tang F, Hou Y.
PMID: 40301136 [PubMed - as supplied by publisher]


The Burden of Esophageal Cancer in Five East Asian Countries From 1990 to 2021 and Its Prediction Until 2036: An Analysis of the Global Burden of Diseases Study 2021.
Thorac Cancer
Guo T, Yuan Y, Zhou T, Hui Y, Wang Y, Zhu W, Shen W, Li L, Yang Y, Cheng H.
PMID: 40296590 [PubMed - indexed for MEDLINE]


The causal relationships between mitochondria and six types of cancer: a Mendelian randomization study.
BMC Cancer
Tang J, Zhang J, Yang R, Chen H, Yu X, Peng W, Zeng P.
PMID: 40295943 [PubMed - indexed for MEDLINE]


Gene expression profiling of lncRNA-HOTAIR and lncRNA-MALAT1 in esophageal cancer: uncovering links to lifestyle factors and diagnostic significance.
Discov Oncol
Ghorbani V, Ghorbian S.
PMID: 40295320 [PubMed]


The incidence of esophageal second primary cancer in head and neck cancer patients.
Medicine (Baltimore)
Chiou TW, Young CK, Hsu KH, Liao CT, Hu YF, Kang CJ, Huang SF.
PMID: 40295278 [PubMed - indexed for MEDLINE]


Impact of Nivolumab Plus Chemotherapy on Conversion Therapy in Clinical Stage IVB HER2-negative Gastric Cancer.
Anticancer Res
Hojo Y, Tomita T, Igeta M, Murakami M, Kohno S, Nakao E, Kitayama Y, Nakamura T, Kurahashi Y, Ishida Y, Hirota S, Shinzaki S, Shinohara H.
PMID: 40295068 [PubMed - indexed for MEDLINE]


The Long-term Outcomes of Borderline Resectable T3 in Locally Advanced Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Triplet Chemotherapy.
Anticancer Res
Kitadani J, Hayata K, Goda T, Tominaga S, Fukuda N, Nakai T, Nagano S, Kawai M.
PMID: 40295038 [PubMed - indexed for MEDLINE]


Preoperative Anemia Is an Independent Prognostic Factor for Esophageal Cancer Patients Who Receive Curative Treatment.
In Vivo
Shimada K, Aoyama T, Hashimoto I, Maezawa Y, Esashi R, Fukuda M, Ju M, Yamamoto S, Kazama K, Kamiya N, Okuda N, Tamagawa A, Numata K, Uchiyama M, Saito A, Yukawa N.
PMID: 40295025 [PubMed - indexed for MEDLINE]


Detection of pathologic complete response using deep neural network-based endoscopic evaluation in patients with esophageal cancer receiving neoadjuvant chemotherapy: a nationwide multicenter retrospective study from 46 Japanese esophageal centers.
Esophagus
Matsuda S, Irino T, Kitagawa Y, Okamura A, Mayanagi S, Booka E, Takeuchi M, Kitadani J, Kanda M, Abe T, Bamba T, Iwatsuki M, Kagaya T, Kurogochi T, Tsubosa Y, Kawakubo H, Kakeji Y, Kono K, Watanabe M, Takeuchi H.
PMID: 40293663 [PubMed - as supplied by publisher]


Initial reduction of the primary tumor or lymph nodes: which is the better prognostic factor in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemotherapy followed by surgery?
Esophagus
Hagi T, Shiraishi O, Terada M, Yamada A, Kohda M, Nakanishi T, Hiraki Y, Kato H, Yasuda A, Shinkai M, Imano M, Yasuda T.
PMID: 40293662 [PubMed - as supplied by publisher]


Factors responsible for the decline in physical fitness during neoadjuvant chemotherapy in older patients with esophageal cancer: an exploratory prospective cohort study.
Support Care Cancer
Harada T, Tsuji T, Ueno J, Konishi N, Yanagisawa T, Hijikata N, Ishikawa A, Hashimoto K, Kagaya H, Tatematsu N, Zenda S, Kotani D, Kojima T, Fujita T.
PMID: 40293534 [PubMed - indexed for MEDLINE]


The Efficacy and Safety of Nivolumab Combined with Nab-Paclitaxel or Oxaliplatin as a First-Line Treatment for Advanced or Metastatic Gastric Cancer and Gastroesophageal Junction Cancer.
J Gastrointest Cancer
Li J, Li S, Zhang Y, Ye S, Liu R, Shi W.
PMID: 40293495 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 36100    Seite 1 von 1805  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Benutzername

Passwort

 

 

Haben Sie Ihr Passwort vergessen?

 

Neu bei My Medline?

Melden Sie sich bei My Medline an!

 

Mehr über My Medline erfahren

mehr >>

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1